Navigating Biosimilar Mandates and Prior Authorization in a Value-Based Cancer Care Model: Jason Bergsbaken, PharmD, MBA, BCOP

Jason Bergsbaken, PharmD, MBA, BCOP, highlights the operational challenges of value-based oncology care while emphasizing the need to balance standardized treatment pathways with flexibility for personalized, biomarker-driven care.